Primigravida dengan hiperemesis gravidarum + kista ovari
DOI: https://doi.org/10.56922/mchc.v4i3.813
HEG Kista Ovari Muntah
Abstract
A 28-year-old patient came to the emergency room of Bintang Amin Hospital with complaints of vomiting approximately 6 times since noon accompanied by nausea. The patient said that abdominal pain was like cramps from 2 hours of SMRS and lately had no appetite due to nausea. Blood pressure 110/75 mmHg, pulse rate 94 x/min, respiratory rate 20x/min, temperature 36.2 °C, oxygen saturation 99%. In the abdominal palpation examination, suprapubic (+) pressure pain was obtained. In the hematological support examination, a decrease in hemoglobin was obtained by 11.1 g/dl, a decrease in hematocrit by 31%, a decrease in MCV of 79 fl, an increase in leukocytes of 23,000 ul and in a complete urine examination, leukocytes H+/(75), Protein H+/(50), ketones HH++++/(150), urobilinogen +/(2) were obtained. Ultrasound examination was obtained D:9.50, D:4.68, GS: not yet visible. The diagnosis in this case is primigravida with hyperemesis gravidarum + ovarian cyst. The management obtained by the patient is observation of complaints, IVFD RL + 1amp neurobion gtt 20 3, pronalges supp, inj ondansetron 2x1 amp, paracetamol 3x500mg. The prognosis in this patient is dubia ad bonam.
Keywords: HEG; Ovarian Cysts; Vomiting.
Pasien usia 28 tahun datang ke IGD Rumah Sakit Bintang Amin dengan keluhan muntah kurang lebih 6x sejak siang disertai mual. Pasien mengatakan nyeri perut seperti keram dari 2 jam SMRS dan akhir akhir ini tidak nafsu makan karna mual. Tekanan darah 110/75 mmHg, denyut nadi 94 x/menit, laju pernapasan 20x/menit, suhu 36,2 °C, saturasi oksigen 99%. Pada pemeriksaan abdomen palpasi didapatkan nyeri tekan (+) suprapubik. Pada pemeriksaan penunjang hematologi didapatkan penurunan hemoglobin dengan 11,1 g/dl, penurunan hematokrit 31 %, penurunan MCV 79 fl, peningkatan leukosit 23.000 ul dan pada pemeriksaan urin lengkap didapatkan leukosit H+/(75), Protein H+/(50), keton HH++++/(150), urobilinogen +/(2). Pemeriksaan USG didapatkan D:9.50, D:4.68, GS:belum tampak. Diagnosis pada kasus ini yaitu primigravida dengan hiperemesis gravidarum+kista ovari. Tatalaksana yang didapat oleh pasien yaitu observasi keluhan, IVFD RL + 1amp neurobion gtt 20 3, pronalges supp, inj ondansetron 2x1 amp, paracetamol 3x500mg. Prognosis pada pasien ini yaitu dubia ad bonam.
Kata Kunci: HEG; Muntah; Kista Ovari.
Downloads
References
Akbar, M. I. A., Tjokroprawiro, B. A., & Hendarto, H. (2020). Ginekologi praktis komprehensif (Vol. 2). Airlangga University Press.
Austin, K., Wilson, K., & Saha, S. (2019). Hyperemesis gravidarum. Nutrition in Clinical Practice, 34(2), 226-241.
Bottomley, C., & Bourne, T. (2009). Diagnosis and management of ovarian cyst accidents. Best practice & research Clinical obstetrics & gynaecology, 23(5), 711-724.
Bridwell, R. E., Koyfman, A., & Long, B. (2022). High risk and low prevalence diseases: Ovarian torsion. The American Journal of Emergency Medicine, 56, 145-150.
Canfell, K. (2016). Tubal ligation and ovarian cancer risk in a large cohort: Substantial variation by histological type.
Cramer, D. W., Hutchison, G. B., Welch, W. R., Scully, R. E., & Ryan, K. J. (1983). Determinants of ovarian cancer risk. I. Reproductive experiences and family History23. JNCI, Journal of the National Cancer Institute, 71, 711.
Dean, C. R., Bruin, C. M., O’Hara, M. E., Roseboom, T. J., Leeflang, M. M., Spijker, R., & Painter, R. C. (2020). The chance of recurrence of hyperemesis gravidarum: A systematic review. European journal of obstetrics & gynecology and reproductive biology: X, 5, 100105.
Fejzo, M. S., Trovik, J., Grooten, I. J., Sridharan, K., Roseboom, T. J., Vikanes, Å., & Mullin, P. M. (2019). Nausea and vomiting of pregnancy and hyperemesis gravidarum. Nature reviews Disease primers, 5(1), 62.
Gabra, A., Habib, H., & Gabra, M. (2019). Hyperemesis gravidarum, diagnosis, and pathogenesis. Crit Care Obstet Gynecol, 5(01), 1-5.
Havnen, G. C., Truong, M. B. T., Do, M. L. H., Heitmann, K., Holst, L., & Nordeng, H. (2019). Women’s perspectives on the management and consequences of hyperemesis gravidarum–a descriptive interview study. Scandinavian journal of primary health care, 37(1), 30-40.
Island, T. (2023). StatPearls Publishing; 2022 Jan. PMID. [Google Scholar].
Jennings, L. K., & Krywko, D. M. (2021). Hyperemesis gravidarum. [Updated 2020 Nov 21]. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing.
Khan, Y. (2019). Hyperemesis gravidarum. InnovAiT, 12(8), 434-441.
Khati, N. J., Kim, T., & Riess, J. (2020). Imaging of benign adnexal disease. Radiologic Clinics, 58(2), 257-273.
Lheureux, S., Braunstein, M., & Oza, A. M. (2019). Epithelial ovarian cancer: evolution of management in the era of precision medicine. CA: a cancer journal for clinicians, 69(4), 280-304.
London, V., Grube, S., Sherer, D. M., & Abulafia, O. (2017). Hyperemesis gravidarum: a review of recent literature. Pharmacology, 100(3-4), 161-171.
Lowe, S. A., & Steinweg, K. E. (2022). Management of hyperemesis gravidarum and nausea and vomiting in pregnancy. Emergency Medicine Australasia, 34(1), 9-15.
Manique, M. E. S., & Ferreira, A. M. A. P. (2022). Polycystic ovary syndrome in adolescence: challenges in diagnosis and management. Revista brasileira de ginecologia e obstetricia, 44(04), 425-433.
Mobeen S., & Apostol R. (2023). Ovarian Cyst. Diakses dari: https://www.ncbi.nlm.nih.gov/books/NBK560541/
Nurmi, M., Rautava, P., Gissler, M., Vahlberg, T., & Polo-Kantola, P. (2018). Recurrence patterns of hyperemesis gravidarum. American Journal of Obstetrics and Gynecology, 219(5), 469-e1.
Pakhomov, S. P., Orlova, V. S., Verzilina, I. N., Sukhih, N. V., Nagorniy, A. V., & Matrosova, A. V. (2021). Risk factors and methods for predicting ovarian hyperstimulation syndrome (OHSS) in the in vitro fertilization. Archives of Razi Institute, 76(5), 1461.
Pavlik, E. J., Ueland, F. R., Miller, R. W., Ubellacker, J. M., DeSimone, C. P., Elder, J., & van Nagell, J. R. (2013). Frequency and disposition of ovarian abnormalities followed with serial transvaginal ultrasonography. Obstetrics & Gynecology, 122(2 PART 1), 210-217.
Terzic, M., Aimagambetova, G., Norton, M., Della Corte, L., Marín-Buck, A., Lisón, J. F., & Cianci, A. (2021). Scoring systems for the evaluation of adnexal masses nature: current knowledge and clinical applications. Journal of Obstetrics and Gynaecology, 41(3), 340-347.
Vinnars, M. T., Forslund, M., Claesson, I. M., Hedman, A., Peira, N., Olofsson, H., & Ulfsdottir, H. (2024). Treatments for hyperemesis gravidarum: A systematic review. Acta Obstetricia et Gynecologica Scandinavica, 103(1), 13-29.
Zhang, R., Siu, M. K., Ngan, H. Y., & Chan, K. K. (2022). Molecular biomarkers for the early detection of ovarian cancer. International Journal of Molecular Sciences, 23(19), 12041.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 THE JOURNAL OF Mother and Child Health Concerns
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
